Net Loss Per Common Share (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Schedule of Net Loss Per Common Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net loss per common share attributable to common stockholders (in thousands, except share and per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Numerator:
Net loss	$	(35,987)	$	(12,669)	$	(96,384)	$	(65,637)
Denominator:
Weighted average shares used to compute basic and diluted net loss per share	181,361,354		156,647,259		175,795,093		123,175,390
Net loss per common share—basic and diluted	$	(0.20)	$	(0.08)	$	(0.55)	$	(0.53)

The shares and net loss per common share, prior to the Colonnade Merger, have been retroactively restated as shares reflecting the exchange ratio of approximately 0.703 shares of the Company per one share of OTI as established in the Colonnade Merger Agreement.

The weighted average number of shares used to compute basic and diluted net loss per share excludes unvested early exercised common stock options subject to repurchase.

Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Common Share

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:

	September 30,
	2022	2021
Options to purchase common stock	21,518,176	24,959,807
Public and private common stock warrants	15,999,900	15,999,996
Restricted Stock Units	18,385,921	4,304,588
Unvested early exercised common stock options	970,090	2,234,455
ESPP shares pending issuance	349,630	—
Unvested RSAs	—	23,288
Vested and early exercised options subject to nonrecourse notes	—	2,172,238
Total	57,223,717	49,694,372